Title:
NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES PF1270A, B AND C
Document Type and Number:
WIPO Patent Application WO/2004/087938
Kind Code:
A1
Abstract:
Novel substances PF1270A, PF1270B and PF1270C represented by the following formula (1) or pharmacologically acceptable salts thereof; a process for producing the same; and a pharmaceutical composition comprising at least one thereof as an active ingredient. This PF1270 substance group exhibits a high affinity with histamine H3 receptor, so that the use thereof as a novel histamine H3 receptor ligand useful as a medicine is promising.
Inventors:
KUSHIDA NOBUAKI (JP)
WATANABE NAOKO (JP)
YAGUCHI TAKASHI (JP)
YOKOYAMA FUMIKAZU (JP)
TSUJIUCHI GOH (JP)
OKUDA TAKAKO (JP)
WATANABE NAOKO (JP)
YAGUCHI TAKASHI (JP)
YOKOYAMA FUMIKAZU (JP)
TSUJIUCHI GOH (JP)
OKUDA TAKAKO (JP)
Application Number:
PCT/JP2004/004416
Publication Date:
October 14, 2004
Filing Date:
March 29, 2004
Export Citation:
Assignee:
MEIJI SEIKA KAISHA (JP)
KUSHIDA NOBUAKI (JP)
WATANABE NAOKO (JP)
YAGUCHI TAKASHI (JP)
YOKOYAMA FUMIKAZU (JP)
TSUJIUCHI GOH (JP)
OKUDA TAKAKO (JP)
KUSHIDA NOBUAKI (JP)
WATANABE NAOKO (JP)
YAGUCHI TAKASHI (JP)
YOKOYAMA FUMIKAZU (JP)
TSUJIUCHI GOH (JP)
OKUDA TAKAKO (JP)
International Classes:
A61P1/04; A61P3/04; A61P3/10; A61P9/10; A61P11/06; A61P23/00; A61P25/04; A61P25/08; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P29/00; A61P43/00; C07D471/20; C12P17/18; (IPC1-7): C12P17/18; A61K31/438; A61P1/04; A61P3/04; A61P3/10; A61P9/10; A61P11/06; A61P23/00; A61P25/04; A61P25/08; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P29/00; A61P43/00; C07D471/20
Domestic Patent References:
| WO2001074813A2 | 2001-10-11 |
Other References:
See also references of EP 1612273A4
Attorney, Agent or Firm:
Oguri, Shohei (13th Floor ARK Mori Building, 12-32, Akasaka 1-chom, Minato-ku Tokyo, JP)
Download PDF: